Home > Insider Trading > Filing (0001209191-15-039437)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1446372	M Paul Silva	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Svp & Corp Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-05-04	1,125	$37.86	19,500	No	4	M	Direct
Common Stock	Disposition	2015-05-04	577	$126.15	18,923	No	4	S	Direct
Common Stock	Disposition	2015-05-04	332	$127.09	18,591	No	4	S	Direct
Common Stock	Disposition	2015-05-04	216	$128.22	18,375	No	4	S	Direct
Common Stock	Acquisiton	2015-05-05	1,687	$45.11	20,062	No	4	M	Direct
Common Stock	Acquisiton	2015-05-05	1,289	$77.31	21,351	No	4	M	Direct
Common Stock	Disposition	2015-05-05	1,676	$121.92	19,675	No	4	S	Direct
Common Stock	Disposition	2015-05-05	1,000	$122.90	18,675	No	4	S	Direct
Common Stock	Disposition	2015-05-05	200	$123.85	18,475	No	4	S	Direct
Common Stock	Disposition	2015-05-05	100	$125.20	18,375	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-05-04	1,125	$0.00	1,125	$37.86
Common Stock	Stock Option (right to buy)	Disposition	2015-05-05	1,687	$0.00	1,687	$45.11
Common Stock	Stock Option (right to buy)	Disposition	2015-05-05	1,289	$0.00	1,289	$77.31

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,375	2022-02-01	No	4	M	Direct
11,813	2023-02-04	No	4	M	Direct
14,179	2024-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	169	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $126.15 (range $125.64 to $126.63).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $127.09 (range $126.87 to $127.40).
Open market sales reported on this line occurred at a weighted average price of $128.22 (range $127.99 to $128.68).
Open market sales reported on this line occurred at a weighted average price of $121.92 (range $121.56 to $122.41).
Open market sales reported on this line occurred at a weighted average price of $122.90 (range $122.58 to $123.33).
Open market sales reported on this line occurred at a weighted average price of $123.85 (range $123.68 to $124.01).
The option vests in 16 quarterly installments from 02/02/2012.
The option vests in 16 quarterly installments from 02/05/2013.
The option vests in 16 quarterly installments from 02/05/2014.